PRESS RELEASE

OAKLAND, Calif. (April 18, 2019) – California Cannabinoids, Inc. has announced that internationally renowned cannabis scientific professional Paul F. Daley, B.S., Ms.S., Ph.D. has joined the business as Chief Scientific Officer, bringing an essential scientific investigation companion and item developer to the brand.

With much more than 30 years of encounter in analytical toxicology and environmental sciences, Dr. Daley will handle all science-connected item improvement and testing for the business as it expands the production and sale of Doug’s Varin™ — a uncommon and very sought-right after cannabis formulation which consists of the highest concentrations of THCV obtainable in the marketplace.

Dr. Daley’s scientific profession contains postdoctoral investigation at Université Laval in Quebéc, P.Q., Canada, and thirty years at the Lawrence Livermore National Laboratory as Environmental Scientist and Chemist. Considering that 2007 he has been Investigation Director and Senior Investigation Chemist at the Alexander Shulgin Investigation Institute.   An entrepreneurial scientist, Dr. Daley also created a cannabis distillation business, and was its laboratory basic manager and top quality handle officer. 

“We are honored to have such a distinguished and broadly recognized scientific professional join our group.  Paul will be crucial to unleashing the reputed advantages of this wonderful cannabinoid as we expand Doug’s Varin items in the marketplace,” stated California Cannabinoids CEO David Lampach.  “His expertise and recognized leadership in the cannabis sector will bolster our drive for innovation and investigation to deliver the advantages of Doug’s Varin to cannabis customers who have been extended awaiting its release.”

Dr. Daley has authored more than sixty peer-reviewed publications in integrated pest management, plant photosynthesis, environmental chemistry, and analytical instrumentation which includes co-authoring The Shulgin Index, Volume One particular: Psychedelic Phenethylamines and Associated Compounds, published by Transform Press in 2011.   

“I am thrilled to be portion of the group who will ultimately make Doug’s Varin obtainable to cannabis customers who have been requesting access for its wonderful wellness advantages,” stated Daley.  “We are at the moment formulating an array of new items which are anticipated to be introduced this summer season. This is an thrilling time to be in the cannabis business enterprise.”

This 1st distribution of Doug’s Varin™ began in February 2019, at 5 SPARC™ locations in the San Francisco Bay Location with the introduction of two THCV-wealthy vape pen item lines: Doug’s Varin™ ORIGINAL (1:1 THCV/THC) and Doug’s Varin™ RELIEF (1:1 THCV/ CBD).  Each include 25% to 30% THCV cannabis oil,discovered naturally in a complete spectrum extraction from uncommon higher THCV cannabis flowers, and are reputed to give extended-awaited private wellness advantages. The higher THCV levels are sufficient to activate the compound’s surprising effects. 

LEVEL™ also presents a THCV enriched Tablingual™ powered by Doug’s Varin known as STIMULATE and is obtainable to cannabis customers at: www.levelblends.com.  

# # #

About Doug’s Varin and California Cannabinoids, Inc.:  Formed in 2017, California Cannabinoids, Inc. is a California corporation primarily based in Oakland, with the mission of supplying the cannabis sector and shoppers access to uncommon cannabinoids. The business is the exclusive provider of Doug’s Varin™ which consists of the highest concentrations of tetrahydrocannabivarin (THCV) at the moment obtainable in the marketplace. CEO David Lampach is a extended-time sector entrepreneur, professional, grower and advocate for clean, secure cannabis.  Prior to founding California Cannabinoids, he was Co-Founder and CEO of Steep Hill Labs and served a consultant to various states regarding the creation and implementation of a variety of elements of health-related and recreational cannabis regulation. To find out much more, go to: DougsVarin.com.

Media Make contact with:       

Kevin Herglotz

415-874-9650

[email protected]